Humana Inc. (NYSE:HUM) Shares Sold by Corebridge Financial Inc.

Corebridge Financial Inc. cut its holdings in Humana Inc. (NYSE:HUM) by 14.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 30,460 shares of the insurance provider’s stock after selling 4,994 shares during the quarter. Corebridge Financial Inc.’s holdings in Humana were worth $7,728,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of HUM. Vanguard Group Inc. increased its position in Humana by 15.8% during the fourth quarter. Vanguard Group Inc. now owns 12,829,210 shares of the insurance provider’s stock worth $3,254,899,000 after buying an additional 1,751,857 shares in the last quarter. KLP Kapitalforvaltning AS acquired a new position in Humana in the 4th quarter valued at about $10,629,000. Sei Investments Co. lifted its holdings in Humana by 16.3% in the 4th quarter. Sei Investments Co. now owns 86,472 shares of the insurance provider’s stock valued at $21,937,000 after purchasing an additional 12,142 shares in the last quarter. American Century Companies Inc. boosted its stake in shares of Humana by 8.8% during the 4th quarter. American Century Companies Inc. now owns 12,655 shares of the insurance provider’s stock worth $3,211,000 after purchasing an additional 1,027 shares during the last quarter. Finally, Mizuho Securities USA LLC grew its holdings in shares of Humana by 46.2% during the fourth quarter. Mizuho Securities USA LLC now owns 11,412 shares of the insurance provider’s stock worth $2,895,000 after buying an additional 3,605 shares in the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, insider Timothy S. Huval sold 3,703 shares of the stock in a transaction dated Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the completion of the transaction, the insider now owns 8,181 shares of the company’s stock, valued at approximately $2,096,463.06. This represents a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Insiders own 0.37% of the company’s stock.

Analysts Set New Price Targets

A number of analysts recently issued reports on HUM shares. Piper Sandler raised their target price on shares of Humana from $270.00 to $288.00 and gave the stock a “neutral” rating in a research report on Wednesday, January 15th. Truist Financial raised their price objective on Humana from $260.00 to $290.00 and gave the stock a “hold” rating in a report on Monday, January 6th. JPMorgan Chase & Co. reduced their target price on Humana from $257.00 to $256.00 and set a “neutral” rating on the stock in a research report on Tuesday, February 18th. StockNews.com cut Humana from a “buy” rating to a “hold” rating in a report on Tuesday, March 18th. Finally, Barclays increased their price objective on shares of Humana from $255.00 to $270.00 and gave the stock an “equal weight” rating in a report on Thursday, February 13th. Eighteen equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat.com, Humana has a consensus rating of “Hold” and an average target price of $285.68.

Humana Price Performance

HUM stock opened at $270.04 on Friday. The firm has a market cap of $32.59 billion, a P/E ratio of 27.14, a price-to-earnings-growth ratio of 2.05 and a beta of 0.57. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. Humana Inc. has a 1 year low of $213.31 and a 1 year high of $406.46. The stock has a 50-day simple moving average of $270.51 and a 200-day simple moving average of $274.93.

Humana (NYSE:HUM) last issued its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. On average, equities analysts predict that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be given a $0.885 dividend. The ex-dividend date is Friday, March 28th. This represents a $3.54 dividend on an annualized basis and a yield of 1.31%. Humana’s payout ratio is currently 35.58%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.